Clinical Trial Update: Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial protocol evaluating prophylactic proton pump inhibition to protect the esophagus during lung radiation therapy, currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Proton Pump Inhibitors

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Primary Lung Cancer, Non Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING